PD-901 treatment in the NF1-associated mouse model significantly reduced tumor burden from 20.6 tumors per animal with DMSO treatment to 12.8 tumors per animal with PD-901 treatment (p=0.0002) (Figure 2C). Here, NF1 is linked to neoplasm.